Integer Holdings Co. (NYSE:ITGR) Receives $139.75 Average PT from Analysts

Integer Holdings Co. (NYSE:ITGR - Get Free Report) has received an average rating of "Moderate Buy" from the eight analysts that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $139.75.

Several equities analysts have recently weighed in on the company. Truist Financial cut their price objective on Integer from $150.00 to $147.00 and set a "buy" rating on the stock in a report on Friday, October 25th. Piper Sandler reissued an "overweight" rating and issued a $140.00 price target (up previously from $125.00) on shares of Integer in a research note on Friday, October 25th. Benchmark lifted their price target on shares of Integer from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Monday, October 21st. Bank of America increased their price objective on Integer from $135.00 to $145.00 and gave the company a "buy" rating in a report on Tuesday, October 1st. Finally, Citigroup boosted their price objective on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. Contravisory Investment Management Inc. raised its position in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 80 shares during the last quarter. HighTower Advisors LLC grew its holdings in Integer by 0.8% during the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider's stock worth $1,579,000 after acquiring an additional 90 shares during the period. Xponance Inc. lifted its stake in shares of Integer by 4.9% in the 2nd quarter. Xponance Inc. now owns 2,112 shares of the medical equipment provider's stock valued at $245,000 after purchasing an additional 99 shares during the period. Azzad Asset Management Inc. ADV boosted its position in shares of Integer by 0.9% during the 3rd quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider's stock valued at $1,504,000 after purchasing an additional 107 shares in the last quarter. Finally, GAMMA Investing LLC grew its stake in Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after purchasing an additional 142 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Price Performance

NYSE ITGR traded down $1.90 on Monday, hitting $138.60. 92,029 shares of the company were exchanged, compared to its average volume of 306,865. Integer has a 1-year low of $86.42 and a 1-year high of $142.00. The company has a market cap of $4.65 billion, a P/E ratio of 43.32, a P/E/G ratio of 2.01 and a beta of 1.09. The company has a current ratio of 3.28, a quick ratio of 2.09 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $131.38 and a two-hundred day moving average of $124.50.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. Integer had a net margin of 6.70% and a return on equity of 11.63%. The firm had revenue of $431.42 million during the quarter, compared to the consensus estimate of $440.59 million. During the same quarter in the prior year, the firm earned $1.27 earnings per share. The business's quarterly revenue was up 8.7% on a year-over-year basis. On average, equities analysts predict that Integer will post 5.33 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.